ALSO NOTED: Acambis inks smallpox contract; Yellow fever outbreak; Researchers see promise for stomach flu vaccines; and much m

Vaccine Market

Then UK's Acambis has inked a contract with the U.S. for its smallpox vaccine--ACAM2000. Report

Breeders in Australia are calling for a national vaccine campaign against equine influenza. Release

Thousands of people in Paraguay blockaded a major highway to highlight their demands for a major yellow fever vaccination campaign. Report

Meanwhile, yellow fever has killed 15 people in Brazil. Report

Farmers in England are facing a 20 million pound bill to vaccinate livestock against blue tongue disease. Report

Vaccine Research

Researchers at the University of North Carolina say that it is possible to develop vaccines to prevent stomach flu triggered by noroviruses, but they would have to be redesigned every year to match the constantly mutating viruses in play. Article

Crucell surprised analysts this week with its announcement that it is dropping its development program for a West Nile vaccine after seeing the number of people infected with the virus in the U.S. slide in recent years. Report

A combined analysis of four phase II/III studies which enrolled more than 20,000 women confirmed that Gardasil has sustained 98 percent to 100 percent efficacy in the prevention of vaccine virus type-related precancerous cervical lesions in young women. The new data were presented at the 19th International Congress on Anti-Cancer Treatment in Paris. Release

By combining an experimental AIDS vaccine with a long-neglected molecule called poly-IC, Rockefeller University scientists discovered that they were able to significantly improve its effectiveness. Release

Rocky Mountain Biosystems has won a $600,000 grant over two years from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to develop its Self-Administered Vaccination Electromechanical technology for influenza vaccination. Release

U.S. officials have granted Lipoxen a patent for one of its DNA vaccines. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.